Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 19/20 | 0.51 |
| ▸ | ADRB1 | P08588 | 8/20 | 0.51 |
| ▸ | DRD3 | P35462 | 3/20 | 0.51 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.51 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.51 |
| ▸ | HTR2A | P28223 | 1/20 | 0.51 |
| ▸ | HTR2C | P28335 | 1/20 | 0.51 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.51 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.51 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.51 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.51 |
| ▸ | SRSF6 | Q13247 | 1/20 | 0.51 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.51 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.51 |
| ▸ | DRD2 | P14416 | 2/20 | 0.32 |
| ▸ | DRD1 | P21728 | 2/20 | 0.32 |
| ▸ | DRD4 | P21917 | 2/20 | 0.32 |
| ▸ | CNR2 | P34972 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18601912 | 1.00 | ADRB2 (0.51) | ADRB2ADRB1DRD3SLC6A2ADRA1D | |
| SCHEMBL15630131 | 1.00 | ADRB2 (0.51) | ADRB2ADRB1DRD3SLC6A2ADRA1D | |
| SCHEMBL16066898 | 0.85 | ADRB2 (0.72) | ADRB2ADRB1DRD3SLC6A2ADRA1D | |
| SCHEMBL13868998 | 0.85 | ADRB2 (0.72) | ADRB2ADRB1DRD3SLC6A2ADRA1D | |
| SCHEMBL16999078 | 0.80 | ADRB2 (0.51) | ADRB2ADRB1DRD3SLC6A2ADRA1D | |
| SCHEMBL15630094 | 0.80 | ADRB2 (0.36) | ADRB2ADRB1DRD3DRD2DRD1 | |
| SCHEMBL19674488 | 0.80 | ADRB2 (0.36) | ADRB2ADRB1DRD3DRD2DRD1 | |
| SCHEMBL18601882 | 0.80 | ADRB2 (0.36) | ADRB2ADRB1DRD3DRD2DRD1 | |
| SCHEMBL13869000 | 0.78 | ADRB2 (0.71) | ADRB2ADRB1DRD3SLC6A2ADRA1D | |
| SCHEMBL28899452 | 0.75 | ADRB2 (0.53) | ADRB2ADRB1DRD3SLC6A2ADRA1D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2897937-B1 | PROCESS FOR THE PREPARATION OF INDACATEROL AND INTERMEDIATES THEREOF | CRYSTAL PHARMA SAU (ES) | 2017-12-06 | — | — | EP | disclosed |
| US-9475772-B2 | Methods for the preparation of indacaterol and pharmaceutically acceptable salts thereof | CRYSTAL PHARMA S.A.U. (ES) | 2016-10-25 | — | — | US | disclosed |
| US-20150225346-A1 | METHODS FOR THE PREPARATION OF INDACATEROL AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF | CRYSTAL PHARMA S.A.U. (ES) | 2015-08-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150225346-A1 | METHODS FOR THE PREPARATION OF INDACATEROL AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF | SQLE, HSD11B1, CYP51A1 | ADRB2 130/4885ADRB1 94/4885DRD3 1957/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.